{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,3]],"date-time":"2026-11-03T03:05:16Z","timestamp":1793675116916,"version":"4.5.1"},"reference-count":22,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"4","content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2023,4]]},"abstract":"<jats:sec>\n                    <jats:title>Purpose:<\/jats:title>\n                    <jats:p>The objective of the study was to compare the efficacy and safety of two concentration of autologous serum (AS) 20% vs 50% in recalcitrant moderate-to-severe dry eye patients.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods:<\/jats:title>\n                    <jats:p>\n                      A double-blind prospective, interventional, and randomized study was done on 44 patients (80 eyes) clinically diagnosed with moderate-to-severe dry eye disease (DED) that was refractory to conventional treatment, and all patients were treated with AS20% or AS50% for 12 weeks. We documented Ocular Surface Disease Index (OSDI), tear film breakup time (TBUT), OXFORD corneal staining score (OSS), and Schirmer test (ST) at baseline, 2,4,8, and 12 weeks. These parameters were compared in both groups and between the groups by using Student\u2019s\n                      <jats:italic toggle=\"yes\">t<\/jats:italic>\n                      -test. The study included 11 males and 33 females.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results:<\/jats:title>\n                    <jats:p>Out of 80 eyes, 33 eyes had moderate and 47 had severe DED. The age of patients in AS20% was 44.73 \u00b1 14.37 years, and in AS50% was 46.41 \u00b1 14.47 years. The most common etiology associated with DED was secondary Sjogren syndrome. In moderate DED, both the groups showed significant improvement in both subjective and objective parameters. But in severe DED, the AS20% group failed to show any significant improvement objectively, though subjective improvement was present.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion:<\/jats:title>\n                    <jats:p>In refractory severe DED patients, AS50% is better option for treatment and in moderate DED both concentrations of autologous serum are effective.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.4103\/ijo.ijo_2684_22","type":"journal-article","created":{"date-parts":[[2023,4,8]],"date-time":"2023-04-08T11:10:52Z","timestamp":1680952252000},"page":"1603-1607","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":12,"title":["Comparative evaluation of effectiveness of twenty versus fifty percent autologous serum eye drops in treatment of dry eye"],"prefix":"10.4103","volume":"71","author":[{"given":"Neha","family":"Kumari","sequence":"first","affiliation":[{"name":"Regional Institute of Ophthalmology, Indira Gandhi Institute of Medical Sciences, Patna, Bihar, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rakhi","family":"Kusumesh","sequence":"additional","affiliation":[{"name":"Regional Institute of Ophthalmology, Indira Gandhi Institute of Medical Sciences, Patna, Bihar, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rekha","family":"Kumari","sequence":"additional","affiliation":[{"name":"Department of Biochemistry Indira Gandhi Institute of Medical Sciences, Bihar, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bibhuti Prassan","family":"Sinha","sequence":"additional","affiliation":[{"name":"Regional Institute of Ophthalmology, Indira Gandhi Institute of Medical Sciences, Patna, Bihar, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vivek","family":"Singh","sequence":"additional","affiliation":[{"name":"Regional Institute of Ophthalmology, Indira Gandhi Institute of Medical Sciences, Patna, Bihar, India"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2023,4,5]]},"reference":[{"key":"R1-20240828","first-page":"2207","article-title":"A clinical study of subtype-based prevalence of dry eye","volume":"7","author":"Rege","year":"2013","journal-title":"J Clin Diagn Res"},{"key":"R2-20240828","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1016\/j.jtos.2017.05.003","article-title":"TFOS DEWS II epidemiology report","volume":"15","author":"Stapleton","year":"2017","journal-title":"Ocul Surf"},{"key":"R3-20240828","doi-asserted-by":"crossref","first-page":"207","DOI":"10.4103\/ijo.IJO_698_17","article-title":"Prevalence and risk factors of dry eye disease in North India: Ocular surface disease index-based cross-sectional hospital study","volume":"66","author":"Titiyal","year":"2018","journal-title":"Indian J Ophthalmol"},{"key":"R5-20240828","doi-asserted-by":"crossref","first-page":"826970","DOI":"10.1155\/2014\/826970","article-title":"Evaluation of the efficacy of 50% autologous serum eye drops in different ocular surface pathologies","volume":"2014","author":"Semeraro","year":"2014","journal-title":"Biomed Res Int"},{"key":"R6-20240828","doi-asserted-by":"crossref","first-page":"1039","DOI":"10.1001\/archopht.1975.01010020815015","article-title":"Clinical experience with a mobile ocular perfusion pump","volume":"93","author":"Ralph","year":"1975","journal-title":"Arch Ophthalmol"},{"key":"R7-20240828","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1016\/S1542-0124(12)70082-4","article-title":"The epidemiology of dry eye disease: Report of the epidemiology subcommittee of the International Dry Eye Workshop (2007)","volume":"5","year":"2007","journal-title":"Ocul Surf"},{"key":"R8-20240828","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1016\/j.jtos.2017.05.001","article-title":"TFOS DEWS II diagnostic methodology report","volume":"15","author":"Wolffsohn","year":"2017","journal-title":"Ocul Surf"},{"key":"R9-20240828","doi-asserted-by":"crossref","first-page":"640","DOI":"10.1097\/00003226-200310000-00008","article-title":"Grading of corneal and conjunctival staining in the context of other dry eye tests","volume":"22","author":"Bron","year":"2003","journal-title":"Cornea"},{"key":"R10-20240828","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1002\/art.1780270415","article-title":"Beneficial effect of artificial tears made with autologous serum in patients with keratoconjunctivitis sicca","volume":"27","author":"Fox","year":"1984","journal-title":"Arthritis Rheum"},{"key":"R11-20240828","doi-asserted-by":"crossref","first-page":"390","DOI":"10.1136\/bjo.83.4.390","article-title":"Treatment of dry eye by autologous serum application in Sjogren's syndrome","volume":"83","author":"Tsubota","year":"1999","journal-title":"Br J Ophthalmol"},{"key":"R12-20240828","doi-asserted-by":"crossref","first-page":"1188","DOI":"10.1136\/bjo.85.10.1188","article-title":"Autologous serum eyedrops for dry eyes and epithelial defects: Clinical and in vitro toxicity studies","volume":"85","author":"Poon","year":"2001","journal-title":"Br J Ophthalmol"},{"key":"R13-20240828","doi-asserted-by":"crossref","first-page":"802","DOI":"10.1097\/00003226-200111000-00005","article-title":"Controlled study of the use of autologous serum in dry eye patients","volume":"20","author":"Tananuvat","year":"2001","journal-title":"Cornea"},{"key":"R14-20240828","doi-asserted-by":"crossref","first-page":"647","DOI":"10.1136\/bjo.2003.026211","article-title":"Comparison of autologous serum eye drops with conventional therapy in a randomised controlled crossover trial for ocular surface disease","volume":"88","author":"Noble","year":"2004","journal-title":"Br J Ophthalmol"},{"key":"R15-20240828","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1016\/j.ajo.2004.08.040","article-title":"The effect of autologous serum eyedrops in the treatment of severe dry eye disease: A prospective randomized case-control study","volume":"139","author":"Kojima","year":"2005","journal-title":"Am J Ophthalmol"},{"key":"R16-20240828","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1007\/s00417-014-2599-1","article-title":"The efficacy of autologous serum eye drops for severe dry eye syndrome: A randomized double-blind crossover study","volume":"252","author":"Celebi","year":"2014","journal-title":"Graefe's Arch Clin Exp Ophthalmol"},{"key":"R17-20240828","doi-asserted-by":"crossref","first-page":"9","DOI":"10.3109\/02713683.2012.720340","article-title":"Comparison of autologous serum eye drops with different diluents","volume":"38","author":"Cho","year":"2013","journal-title":"Curr Eye Res"},{"key":"R18-20240828","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1097\/ICO.0000000000000147","article-title":"Comparison of clinical efficacies of autologous serum eye drops in patients with primary and secondary sj\u00f6gren syndrome","volume":"33","author":"Hwang","year":"2014","journal-title":"Cornea"},{"key":"R19-20240828","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1016\/j.ajo.2007.03.016","article-title":"Comparison of autologous serum and umbilical cord serum eye drops for dry eye syndrome","volume":"144","author":"Yoon","year":"2007","journal-title":"Am J Ophthalmol"},{"key":"R20-20240828","doi-asserted-by":"crossref","first-page":"e396","DOI":"10.1111\/aos.14953","article-title":"Autologous versus allogeneic versus umbilical cord sera for the treatment of severe dry eye disease: A double-blind randomized clinical trial","volume":"100","author":"Rodr\u00edguez Calvo-de-Mora","year":"2022","journal-title":"Acta Ophthalmol"},{"key":"R21-20240828","doi-asserted-by":"crossref","first-page":"1072","DOI":"10.1097\/ICO.0000000000000515","article-title":"Comparative evaluation of silicone hydrogel contact lenses and autologous serum for management of Sj\u00f6gren syndrome-associated dry eye","volume":"34","author":"Li","year":"2015","journal-title":"Cornea"},{"key":"R22-20240828","doi-asserted-by":"crossref","first-page":"21","DOI":"10.3109\/02713683.2013.824987","article-title":"The application of autologous serum eye drops in severe dry eye patients;Subjective and objective parameters before and after treatment","volume":"39","author":"Jirsova","year":"2014","journal-title":"Curr Eye Res"},{"key":"R23-20240828","doi-asserted-by":"crossref","first-page":"684","DOI":"10.3109\/02713683.2012.674609","article-title":"Randomized Double-blind clinical trial of autologous serum versus artificial tears in dry eye syndrome","volume":"37","author":"Urzua","year":"2012","journal-title":"Curr Eye Res"}],"container-title":["Indian Journal of Ophthalmology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/10.4103\/IJO.IJO_2684_22","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,14]],"date-time":"2026-08-14T16:26:31Z","timestamp":1786724791000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/10.4103\/IJO.IJO_2684_22"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,4]]},"references-count":22,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2023]]}},"URL":"https:\/\/doi.org\/10.4103\/ijo.ijo_2684_22","relation":{},"ISSN":["0301-4738","1998-3689"],"issn-type":[{"value":"0301-4738","type":"print"},{"value":"1998-3689","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,4]]},"assertion":[{"value":"2022-10-13","name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2023-02-13","name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}}]}}